BCEIE › News › NURECA

Results

Nureca Q1 FY27: net profit up 277% to ₹3.07 crore, revenue up 18%

Nureca (BSE: NURECA) said it has published its Q1 FY27 results (consolidated), reporting revenue of ₹40.34 crore (+18.0% year on year), net profit of ₹3.07 crore (+277.4%), earnings per share of ₹3.21. The company is valued at about ₹302 crore.

BCEIE News Desk · Published 21 Oct 2026, 02:10 pm IST · Filing received 21 Oct 2026, 01:53 pm IST

What happened

Nureca (BSE: NURECA) informed the stock exchanges on 21 October 2026 at 01:53 PM that it has published its Q1 FY27 results (consolidated), reporting revenue of ₹40.34 crore (+18.0% year on year), net profit of ₹3.07 crore (+277.4%), earnings per share of ₹3.21.

From the filing: "Approved the unaudited standalone and consolidated Financial Results, Cash Flow Statement and Statement of Assets and liabilities of the Company for the second quarter and half year ended September 30, 202 6 ."

Company snapshot

Nureca is a micro-cap company, with a market value of about ₹302 crore.

The stock last traded at ₹316.5, against a 52-week range of ₹204–₹376 (15.8% below the high).

Before this filing the shares had moved −5.8% over the month and +10.9% over three months. Average daily turnover over the last 20 sessions was about ₹0.24 crore.

Promoters held 68.09% at the end of Q1 FY27. Foreign institutions owned 0.11% and domestic institutions 0.24%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY26340.80.81
Q2 FY26724.44.44
Q3 FY26403.73.91
Q4 FY2635-6.1-6.45
Q1 FY27403.13.21

What history shows

This is not the company's first results disclosure: BCEIE has 4 earlier filings of this kind on record since May 2026.

After those filings, the stock fell 7.1% on average the next trading day and was down 3.4% on average after five days (4 filings with price data).

Market-wide, 9,619 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.

Past reactions describe what happened before; they are not a forecast.

Earlier filings of this kind
DateFilingNext day5 days
21 Jul 2026Unaudited Financial Results For The Quarter Ended June 30, 2026+1.6%+11.8%
21 Jul 2026Board Meeting Outcome for Un-Audited Financial Results For The…+1.6%+11.8%
29 May 2026, the financial results for the period ended March 31, 2026.−15.7%−18.5%
29 May 2026Nureca Limited Has Informed The Exchange Regarding The Audited…−15.7%−18.5%

What to watch

  • Management commentary, margins and order book or guidance in the investor presentation.
  • 21 October 2026: Board meeting — Financial Results/Other business matters.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.